TARRIFF SCOTT (CEO) received a stock award from EAGLE PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/2/2023ACC: 0001209191-23-014646
DirectorOfficer· CEO
Since Jun 2018
+67.79K
Net shares
Net buyer
$87.2K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
70.90K acquired · 3.11K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−3.11K
Price / share
$28.00
Trade value
$87.16K
% of position
0.2%
2/28/2023
1.57M→1.57M
Common Stock
Direct
Shares
+70.90K
Price / share
—
Trade value
—
% of position
4.5%
3/1/2023
1.57M→1.64M
Total
Net shares
+67.79K
Net value
-$87.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/28/2023 | F · Tax Withholding | −3.11K | $28.00 | $87.16K | 0.2% | 1.57M | 1.57M |
| Common Stock Direct | 3/1/2023 | A · Award | +70.90K | — | — | 4.5% | 1.57M | 1.64M |
| Total | +67.79K | -$87.16K | ||||||
Derivative Transactions0
No derivative transactions reported